Table 2 SHR erythrocyte saturated fatty acid composition (%total fatty acids) following the consumption of diets with a 25:1 ω-6/ω-3 FAR for 6 weeks^§

Capric

C10:0

nd

nd

nd

nd

nd

Undecanoic

C11:0

nd

nd

nd

nd

nd

Lauric

C12:0

0.24 ± 0.00^a

0.43 ± 0.22^ab

0.06 ± 0.01^a

0.12 ± 0.04^ab

0.16 ± 0.06^b

Tridecyclic

C13:0

nd

nd

nd

nd

nd

Myristic

C14:0

0.17 ± 0.02^a

0.23 ± 0.05^ab

0.15 ± 0.03^a

0.20 ± 0.03^ab

0.29 ± 0.04^b

Pentadecanoic

C15:0

0.12 ± 0.01^a

0.14 ± 0.01^ab

0.13 ± 0.01^ab

0.17 ± 0.02^ab

0.18 ± 0.01^b

Palmitic

C16:0

60.08 ± 5.47^a

27.08 ± 1.61^b

24.71 ± 1.60^b

23.77 ± 0.90^b

23.05 ± 0.46^b

Heptadecanoic

C17:0

nd

nd

nd

nd

nd

Stearic

C18:0

11.15 ± 2.80^a

16.80 ± 1.04^b

16.33 ± 1.05^b

15.01 ± 0.52^ab

14.52 ± 0.29^ab

Arachidic

C20:0

nd

0.20 ± 0.01

nd

nd

nd

Behenic

C22:0

nd

nd

nd

nd

nd

Lignoceric

C24:0

nd

nd

nd

nd

nd

Total SFAs

71.82 ± 3.43 ^a

45.25 ± 2.36 ^b

41.72 ± 2.71 ^b

39.65 ± 1.41 ^b

38.63 ± 0.80 ^b